Nanomedicine of tyrosine kinase inhibitors

Recent progress in nanomedicine and targeted therapy brings new breeze into the field of therapeutic applications of tyrosine kinase inhibitors (TKIs). These drugs are known for many side effects due to non-targeted mechanism of action that negatively impact quality of patients' lives or that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Smidova, Veronika, Michalek, Petr, Goliasova, Zita, Eckschlager, Tomas, Hodek, Petr, Adam, Vojtech, Heger, Zbynek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778595/
https://www.ncbi.nlm.nih.gov/pubmed/33408767
http://dx.doi.org/10.7150/thno.48662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778595/
https://www.ncbi.nlm.nih.gov/pubmed/33408767
http://dx.doi.org/10.7150/thno.48662

Ejemplares similares